找回密码
 To register

QQ登录

只需一步,快速开始

扫一扫,访问微社区

Titlebook: Diagnostic and Therapeutic Advances in Hematologic Malignancies; Martin S. Tallman,Leo I. Gordon Book 1999 Springer Science+Business Media

[复制链接]
查看: 11967|回复: 57
发表于 2025-3-21 16:15:30 | 显示全部楼层 |阅读模式
书目名称Diagnostic and Therapeutic Advances in Hematologic Malignancies
编辑Martin S. Tallman,Leo I. Gordon
视频video
丛书名称Cancer Treatment and Research
图书封面Titlebook: Diagnostic and Therapeutic Advances in Hematologic Malignancies;  Martin S. Tallman,Leo I. Gordon Book 1999 Springer Science+Business Media
出版日期Book 1999
关键词AIDS; bone marrow; cell; classification; leukemia; lymphoma; molecular biology; molecular medicine; stem cel
版次1
doihttps://doi.org/10.1007/b102331
isbn_softcover978-1-4757-8267-7
isbn_ebook978-0-585-38571-6Series ISSN 0927-3042 Series E-ISSN 2509-8497
issn_series 0927-3042
copyrightSpringer Science+Business Media New York 1999
The information of publication is updating

书目名称Diagnostic and Therapeutic Advances in Hematologic Malignancies影响因子(影响力)




书目名称Diagnostic and Therapeutic Advances in Hematologic Malignancies影响因子(影响力)学科排名




书目名称Diagnostic and Therapeutic Advances in Hematologic Malignancies网络公开度




书目名称Diagnostic and Therapeutic Advances in Hematologic Malignancies网络公开度学科排名




书目名称Diagnostic and Therapeutic Advances in Hematologic Malignancies被引频次




书目名称Diagnostic and Therapeutic Advances in Hematologic Malignancies被引频次学科排名




书目名称Diagnostic and Therapeutic Advances in Hematologic Malignancies年度引用




书目名称Diagnostic and Therapeutic Advances in Hematologic Malignancies年度引用学科排名




书目名称Diagnostic and Therapeutic Advances in Hematologic Malignancies读者反馈




书目名称Diagnostic and Therapeutic Advances in Hematologic Malignancies读者反馈学科排名




单选投票, 共有 1 人参与投票
 

0票 0.00%

Perfect with Aesthetics

 

1票 100.00%

Better Implies Difficulty

 

0票 0.00%

Good and Satisfactory

 

0票 0.00%

Adverse Performance

 

0票 0.00%

Disdainful Garbage

您所在的用户组没有投票权限
发表于 2025-3-21 23:16:05 | 显示全部楼层
0927-3042 Overview: 978-1-4757-8267-7978-0-585-38571-6Series ISSN 0927-3042 Series E-ISSN 2509-8497
发表于 2025-3-22 02:28:42 | 显示全部楼层
发表于 2025-3-22 07:12:41 | 显示全部楼层
发表于 2025-3-22 12:30:19 | 显示全部楼层
Ziming Zheng,Andrew A. Chien,Keita Teranishiproliferative disease arising in immunocompromised populations, in Hodgkin’s disease, and in peripheral T-cell lymphoma. The association is of interest in terms of the pathogenesis of these tumors and is becoming important in terms of new approaches to treatment. The purpose of this chapter is to re
发表于 2025-3-22 13:06:40 | 显示全部楼层
https://doi.org/10.1007/978-3-319-17353-5n of either B or T lymphocytes but differing in clinical presentation, prognosis, and treatment strategies. In 1997, the estimated number of new cases of NHL was 53,600, with a slight preponderance toward males (M/F ratio: 1.3).. The estimated number of deaths secondary to NHL was 23,800 (44.4%) in
发表于 2025-3-22 19:29:56 | 显示全部楼层
发表于 2025-3-23 00:04:09 | 显示全部楼层
Ziming Zheng,Andrew A. Chien,Keita Teranishidistinct clinical and pathologic subtype that accounts for approximately 10% of acute myeloid leukemia (AML) cases. The unique features of APL have been well described [.–.] and include a characteristic morphologic appearance ., a reciprocal translocation between the long arms of chromosomes 15 and
发表于 2025-3-23 01:34:41 | 显示全部楼层
发表于 2025-3-23 07:59:26 | 显示全部楼层
Rui Pinheiro,Nuno Roma,Pedro Tomásproliferation of clonal plasma cells that are resistant to standard doses of commonly employed agents at the time of diagnosis, resulting in complete remission (CR) rates of only 5%–10% and median survival of approximately three years. This inherent resistance is probably due to an array of molecula
 关于派博传思  派博传思旗下网站  友情链接
派博传思介绍 公司地理位置 论文服务流程 影响因子官网 SITEMAP 大讲堂 北京大学 Oxford Uni. Harvard Uni.
发展历史沿革 期刊点评 投稿经验总结 SCIENCEGARD IMPACTFACTOR 派博系数 清华大学 Yale Uni. Stanford Uni.
|Archiver|手机版|小黑屋| 派博传思国际 ( 京公网安备110108008328) GMT+8, 2025-5-11 16:07
Copyright © 2001-2015 派博传思   京公网安备110108008328 版权所有 All rights reserved
快速回复 返回顶部 返回列表